News

  1. Home
  2. News
  3. Notice regarding the conclusion of the SDGs Lease "Mirai 2030®" (donation type) contract
2024/12/4 Company Information Individual Customers Corporate Customers

Notice regarding the conclusion of the SDGs Lease "Mirai 2030®" (donation type) contract

Ito Kanpo Pharmaceutical Co., Ltd. has signed a contract with Sumitomo Mitsui Finance & Leasing Co., Ltd. to support the SDGs lease "Mirai 2030®" (donation type), which will donate to public interest incorporated foundations or certified NPOs that contribute to the achievement of the SDGs.

The donation will be made to the Certified NPO National Network for Supporting Children with Incurable Diseases, which provides support to children with incurable diseases. As a company that supports health, we will do our best to contribute to the achievement of the SDGs, however small our contribution may be.

[Sumitomo Mitsui Finance and Leasing Co., Ltd.]
https://www.smfl.co.jp/service/sdgs_lease/
*The list of contracted companies for the SDGs lease "Mirai 2030®" can be found under "Donation Type (SMFL)" on the page.

[Donation recipient]
Certified NPO National Network for Supporting Children with Incurable Diseases
https://nanbyonet.or.jp/

 

Return to the information list